PLEASE READ – IMPORTANT INFORMATION: CSL Behring and Ferring Pharmaceuticals have announced a recall of lots of Stimate®.

 

 

In order to keep you informed of recalls of products that you or your families may use,  we are sharing a communication received by CSL Behring concerning a widespread Stimate recall along with a Medical Advisory issued by the National Hemophilia Foundation (NHF).  If Stimate is part of your treatment plan, please contact your medical team for further discussion regarding your individual care. 

Click here for Medical Advisory #426

Statement from CSL Behring:

Ferring Pharmaceuticals, Inc., is initiating a precautionary voluntary recall of all batches of Stimate® Nasal Spray (desmopressin acetate) 1.5 mg/mL. During routine testing, a low volume was observed and the analysis of the solution from this sample generated an out-of-specification result. Stimate® is owned and manufactured by Ferring Pharmaceuticals, Inc., and distributed and sold by CSL Behring LLC. CSL Behring has proactively notified the distributors, specialty pharmacies, impacted HCPs, and advocacy partners regarding this situation.

Our commitment to patient care continues to be a key priority and guiding principle for CSL Behring. We will keep the community apprised of the situation so that therapy management decisions can be made from an informed position. We encourage patients to contact their pharmacy regarding their individual prescription and, if necessary, contact their physician about their treatment plan.